Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 3/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29895753 | 1.00 | DYRK1A (0.47) | DYRK1AAHRALOX5MEN1KMT2A | |
| SCHEMBL24665199 | 0.87 | ALOX5 (0.44) | DYRK1AAHRALOX5MEN1KMT2A | |
| SCHEMBL9109351 | 0.84 | AHR (0.44) | DYRK1AAHRALOX5MEN1KMT2A | |
| SCHEMBL8686 | 0.83 | ALOX5 (0.46) | DYRK1AAHRALOX5MEN1KMT2A | |
| SCHEMBL30392062 | 0.83 | ALOX5 (0.46) | DYRK1AAHRALOX5MEN1KMT2A | |
| SCHEMBL25493786 | 0.81 | AHR (0.44) | DYRK1AAHRALOX5MEN1KMT2A | |
| SCHEMBL19168708 | 0.80 | AHR (0.42) | DYRK1AAHRALOX5MEN1KMT2A | |
| SCHEMBL24984157 | 0.80 | AHR (0.46) | DYRK1AAHRALOX5MEN1KMT2A | |
| SCHEMBL15291687 | 0.80 | AHR (0.42) | DYRK1AAHRALOX5MEN1KMT2A | |
| SCHEMBL9109501 | 0.79 | AHR (0.49) | DYRK1AAHRALOX5MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11535637-B2 | Compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2022-12-27 | — | — | US | disclosed |
| US-20200216475-A1 | COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-07-09 | — | — | US | disclosed |
| US-9484540-B2 | Oxygen-containing fused ring derivative and organic electroluminescence device comprising the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-11-01 | — | — | US | disclosed |
| US-9484540-B2 | Oxygen-containing fused ring derivative and organic electroluminescence device comprising the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-11-01 | — | — | US | disclosed |
| US-9484540-B2 | Oxygen-containing fused ring derivative and organic electroluminescence device comprising the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-11-01 | — | — | US | disclosed |
| US-9373792-B2 | Anthracene derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-21 | — | — | US | disclosed |
| US-9373792-B2 | Anthracene derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-21 | — | — | US | disclosed |
| US-9373792-B2 | Anthracene derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-21 | — | — | US | disclosed |
| EP-2436679-B1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | IDEMITSU KOSAN CO (JP) | 2016-01-06 | — | — | EP | disclosed |
| US-20150372237-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | IDEMITSU KOSAN CO., LTD (JP) | 2015-12-24 | — | — | US | disclosed |
| US-20140159005-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | IIDEMITSU KOSAN CO., LTD (JP) | 2014-06-12 | — | — | US | disclosed |
| US-8629430-B2 | Anthracene derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-01-14 | — | — | US | disclosed |
| US-8629430-B2 | Anthracene derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-01-14 | — | — | US | disclosed |
| US-8629430-B2 | Anthracene derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-01-14 | — | — | US | disclosed |
| US-20130306958-A1 | OXYGEN-CONTAINING FUSED RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2013-11-21 | — | — | US | disclosed |
| US-20130306958-A1 | OXYGEN-CONTAINING FUSED RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2013-11-21 | — | — | US | disclosed |
| EP-2644607-A1 | OXYGENATED FUSED RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2013-10-02 | — | — | EP | disclosed |
| US-20120138914-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-07 | — | — | US | disclosed |
| US-20120138914-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-07 | — | — | US | disclosed |
| US-20120138914-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140159005-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | SOX18, ANXA1, ANXA11 | DYRK1A 4351/4885AHR 314/4885ALOX5 1779/4885 |
| US-11535637-B2 | Compound and organic light emitting element comprising same | NR2E3, NR4A2, NR2C2 | DYRK1A 2282/4885AHR 1044/4885ALOX5 3736/4885 |
| US-20150372237-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | SOX18, ANXA1, ANXA11 | DYRK1A 4351/4885AHR 314/4885ALOX5 1779/4885 |
| US-20120138914-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | SOX18, ANXA1, ANXA11 | DYRK1A 4351/4885AHR 314/4885ALOX5 1779/4885 |
| US-20200216475-A1 | COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | NR2E3, NR4A2, NR4A1 | DYRK1A 1861/4885AHR 109/4885ALOX5 2722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.